25 XP   0   0   10

NatureCell Co.Ltd
Buy, Hold or Sell?

Let's analyse Naturecell together

PenkeI guess you are interested in NatureCell Co.Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of NatureCell Co.Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about NatureCell Co.Ltd

I send you an email if I find something interesting about NatureCell Co.Ltd.

Quick analysis of Naturecell (30 sec.)










What can you expect buying and holding a share of Naturecell? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩1,048.61
Expected worth in 1 year
₩1,273.13
How sure are you?
39.1%

+ What do you gain per year?

Total Gains per Share
₩224.52
Return On Investment
3.2%

For what price can you sell your share?

Current Price per Share
₩7,010.00
Expected price per share
₩6,880 - ₩8,260
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Naturecell (5 min.)




Live pricePrice per Share (EOD)

₩7,010.00

Intrinsic Value Per Share

₩-109.93 - ₩49.06

Total Value Per Share

₩938.69 - ₩1,097.67

2. Growth of Naturecell (5 min.)




Is Naturecell growing?

Current yearPrevious yearGrowGrow %
How rich?$53.8m$44.9m$4.5m9.1%

How much money is Naturecell making?

Current yearPrevious yearGrowGrow %
Making money$172.7k-$3.6m$3.7m2,188.1%
Net Profit Margin1.0%-82.4%--

How much money comes from the company's main activities?

3. Financial Health of Naturecell (5 min.)




4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Naturecell? (5 min.)

Welcome investor! Naturecell's management wants to use your money to grow the business. In return you get a share of Naturecell.

What can you expect buying and holding a share of Naturecell?

First you should know what it really means to hold a share of Naturecell. And how you can make/lose money.

Speculation

The Price per Share of Naturecell is ₩7,010. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Naturecell.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Naturecell, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩1,048.61. Based on the TTM, the Book Value Change Per Share is ₩56.13 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-52.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Naturecell.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.010.0%0.000.0%-0.060.0%-0.050.0%-0.040.0%
Usd Book Value Change Per Share-0.010.0%0.040.0%-0.040.0%0.010.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.010.0%0.040.0%-0.040.0%0.010.0%0.040.0%
Usd Price Per Share6.19-9.84-13.09-10.69-11.08-
Price to Earnings Ratio-120.61--65.06--58.28--40.57--28.46-
Price-to-Total Gains Ratio-644.27--242.32--362.20--187.94--422.99-
Price to Book Ratio7.38-13.08-18.14-14.86-16.22-
Price-to-Total Gains Ratio-644.27--242.32--362.20--187.94--422.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.608
Number of shares178
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.040.01
Usd Total Gains Per Share0.040.01
Gains per Quarter (178 shares)7.992.32
Gains per Year (178 shares)31.979.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10322209-1
2064540198
30968602817
4012811803726
5016015004635
6019218205644
7022421406553
8025624607462
9028827808471
10032031009380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%3.014.00.017.6%7.016.00.030.4%7.016.00.030.4%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%5.012.00.029.4%9.014.00.039.1%9.014.00.039.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.023.00.0%0.00.023.00.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%5.012.00.029.4%9.014.00.039.1%9.014.00.039.1%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Naturecell

About NatureCell Co.Ltd

NatureCell Co.,Ltd. manufactures and sells canned and health functional food products, beverages, stem cell, and cosmetics in South Korea and internationally. The company's products comprise fruit drinks, aloe vera drinks, coffee, energy drinks, and Korean sauces, as well as offers domestic products and ETC products under the SAMMI and OEM brands. It also provides services for the preservation of blood cells, such as endothelial progenitor cells, mononuclear cells, and platelet rich plasma products. The company was formerly known as RNL Sammi CO., Ltd. and changed its name to NatureCell Co.,Ltd. in April 2013. NatureCell Co.,Ltd. was founded in 1960 and is based in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-02-09 20:59:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of NatureCell Co.Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Naturecell earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Naturecell to the Pharmaceuticals industry mean.
  • A Net Profit Margin of -26.7% means that ₩-0.27 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of NatureCell Co.Ltd:

  • The MRQ is -26.7%. The company is making a huge loss. -2
  • The TTM is 1.0%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ-26.7%TTM1.0%-27.6%
TTM1.0%YOY-82.4%+83.4%
TTM1.0%5Y-68.2%+69.2%
5Y-68.2%10Y-50.4%-17.9%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.7%8.0%-34.7%
TTM1.0%9.5%-8.5%
YOY-82.4%10.1%-92.5%
5Y-68.2%12.1%-80.3%
10Y-50.4%11.8%-62.2%
1.1.2. Return on Assets

Shows how efficient Naturecell is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Naturecell to the Pharmaceuticals industry mean.
  • -1.4% Return on Assets means that Naturecell generated ₩-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of NatureCell Co.Ltd:

  • The MRQ is -1.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.4%TTM0.0%-1.4%
TTM0.0%YOY-5.8%+5.7%
TTM0.0%5Y-4.6%+4.6%
5Y-4.6%10Y-3.3%-1.3%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.4%4.4%-5.8%
TTM0.0%5.2%-5.2%
YOY-5.8%5.1%-10.9%
5Y-4.6%5.0%-9.6%
10Y-3.3%5.8%-9.1%
1.1.3. Return on Equity

Shows how efficient Naturecell is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Naturecell to the Pharmaceuticals industry mean.
  • -1.5% Return on Equity means Naturecell generated ₩-0.02 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of NatureCell Co.Ltd:

  • The MRQ is -1.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 0.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-1.5%TTM0.5%-2.0%
TTM0.5%YOY-8.0%+8.6%
TTM0.5%5Y-8.6%+9.1%
5Y-8.6%10Y-6.2%-2.4%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.5%6.5%-8.0%
TTM0.5%8.0%-7.5%
YOY-8.0%6.8%-14.8%
5Y-8.6%7.4%-16.0%
10Y-6.2%10.7%-16.9%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of NatureCell Co.Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Naturecell is operating .

  • Measures how much profit Naturecell makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Naturecell to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of NatureCell Co.Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.6%+0.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.2%-12.2%
TTM-11.7%-11.7%
YOY-13.5%-13.5%
5Y-11.1%-11.1%
10Y-0.6%13.2%-13.8%
1.2.2. Operating Ratio

Measures how efficient Naturecell is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 2.00 means that the operating costs are ₩2.00 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of NatureCell Co.Ltd:

  • The MRQ is 2.001. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.124. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.001TTM1.124+0.877
TTM1.124YOY0.624+0.500
TTM1.1245Y0.705+0.419
5Y0.70510Y0.970-0.265
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0011.311+0.690
TTM1.1241.311-0.187
YOY0.6241.242-0.618
5Y0.7051.241-0.536
10Y0.9701.210-0.240
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of NatureCell Co.Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Naturecell is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 15.50 means the company has ₩15.50 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of NatureCell Co.Ltd:

  • The MRQ is 15.501. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.880. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ15.501TTM7.880+7.621
TTM7.880YOY4.234+3.646
TTM7.8805Y5.203+2.677
5Y5.20310Y4.324+0.880
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ15.5012.077+13.424
TTM7.8802.028+5.852
YOY4.2342.173+2.061
5Y5.2032.048+3.155
10Y4.3242.053+2.271
1.3.2. Quick Ratio

Measures if Naturecell is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Naturecell to the Pharmaceuticals industry mean.
  • A Quick Ratio of 1.34 means the company can pay off ₩1.34 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of NatureCell Co.Ltd:

  • The MRQ is 1.336. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 3.590. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.336TTM3.590-2.253
TTM3.590YOY3.422+0.168
TTM3.5905Y3.769-0.179
5Y3.76910Y2.907+0.862
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3361.166+0.170
TTM3.5901.457+2.133
YOY3.4221.850+1.572
5Y3.7691.702+2.067
10Y2.9071.339+1.568
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of NatureCell Co.Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Naturecell assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Naturecell to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.07 means that Naturecell assets are financed with 7.4% credit (debt) and the remaining percentage (100% - 7.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of NatureCell Co.Ltd:

  • The MRQ is 0.074. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.230. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.074TTM0.230-0.157
TTM0.230YOY0.267-0.036
TTM0.2305Y0.236-0.005
5Y0.23610Y0.242-0.006
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0740.333-0.259
TTM0.2300.333-0.103
YOY0.2670.301-0.034
5Y0.2360.322-0.086
10Y0.2420.346-0.104
1.4.2. Debt to Equity Ratio

Measures if Naturecell is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Naturecell to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 8.0% means that company has ₩0.08 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of NatureCell Co.Ltd:

  • The MRQ is 0.080. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.361. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.080TTM0.361-0.282
TTM0.361YOY0.416-0.054
TTM0.3615Y0.376-0.014
5Y0.37610Y0.371+0.005
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0800.499-0.419
TTM0.3610.499-0.138
YOY0.4160.444-0.028
5Y0.3760.481-0.105
10Y0.3710.542-0.171
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of NatureCell Co.Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Naturecell generates.

  • Above 15 is considered overpriced but always compare Naturecell to the Pharmaceuticals industry mean.
  • A PE ratio of -120.61 means the investor is paying ₩-120.61 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of NatureCell Co.Ltd:

  • The EOD is -109.236. Based on the earnings, the company is expensive. -2
  • The MRQ is -120.611. Based on the earnings, the company is expensive. -2
  • The TTM is -65.059. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-109.236MRQ-120.611+11.375
MRQ-120.611TTM-65.059-55.553
TTM-65.059YOY-58.282-6.777
TTM-65.0595Y-40.571-24.487
5Y-40.57110Y-28.459-12.112
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD-109.23631.542-140.778
MRQ-120.61123.095-143.706
TTM-65.05922.342-87.401
YOY-58.28224.103-82.385
5Y-40.57127.921-68.492
10Y-28.45928.455-56.914
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of NatureCell Co.Ltd:

  • The EOD is -40.454. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -44.667. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 39.163. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-40.454MRQ-44.667+4.213
MRQ-44.667TTM39.163-83.830
TTM39.163YOY-33.755+72.918
TTM39.1635Y-27.667+66.830
5Y-27.66710Y33.807-61.474
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD-40.45444.702-85.156
MRQ-44.66728.026-72.693
TTM39.16331.298+7.865
YOY-33.75529.475-63.230
5Y-27.66725.820-53.487
10Y33.80726.836+6.971
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Naturecell is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 7.38 means the investor is paying ₩7.38 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of NatureCell Co.Ltd:

  • The EOD is 6.685. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.381. Based on the equity, the company is overpriced. -1
  • The TTM is 13.080. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.685MRQ7.381-0.696
MRQ7.381TTM13.080-5.699
TTM13.080YOY18.140-5.060
TTM13.0805Y14.855-1.775
5Y14.85510Y16.221-1.366
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD6.6853.869+2.816
MRQ7.3812.327+5.054
TTM13.0802.472+10.608
YOY18.1402.936+15.204
5Y14.8553.317+11.538
10Y16.2213.878+12.343
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of NatureCell Co.Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---12.01456.129-121%-52.224+335%16.302-174%45.592-126%
Book Value Per Share--1048.615975.286+8%898.046+17%1067.550-2%981.258+7%
Current Ratio--15.5017.880+97%4.234+266%5.203+198%4.324+259%
Debt To Asset Ratio--0.0740.230-68%0.267-72%0.236-69%0.242-70%
Debt To Equity Ratio--0.0800.361-78%0.416-81%0.376-79%0.371-79%
Dividend Per Share----0%-0%-0%-0%
Eps---16.0433.706-533%-71.981+349%-61.510+283%-44.599+178%
Free Cash Flow Per Share---43.320-12.692-71%-200.255+362%-88.009+103%-61.410+42%
Free Cash Flow To Equity Per Share---43.32048.401-190%18.376-336%70.894-161%57.595-175%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--49.055--------
Intrinsic Value_10Y_min---109.926--------
Intrinsic Value_1Y_max---352.707--------
Intrinsic Value_1Y_min---346.654--------
Intrinsic Value_3Y_max---787.192--------
Intrinsic Value_3Y_min---757.020--------
Intrinsic Value_5Y_max---893.095--------
Intrinsic Value_5Y_min---852.405--------
Market Cap372065564000.000-33%496576387440.000776908846060.000-36%1024856030500.000-52%814622224249.412-39%826460034112.536-40%
Net Profit Margin---0.2670.010-2897%-0.824+209%-0.682+156%-0.504+89%
Operating Margin----0%-0%-0%-0.0060%
Operating Ratio--2.0011.124+78%0.624+221%0.705+184%0.970+106%
Pb Ratio6.685-10%7.38113.080-44%18.140-59%14.855-50%16.221-54%
Pe Ratio-109.236+9%-120.611-65.059-46%-58.282-52%-40.571-66%-28.459-76%
Price Per Share7010.000-10%7740.00012305.000-37%16362.500-53%13356.471-42%13845.217-44%
Price To Free Cash Flow Ratio-40.454+9%-44.66739.163-214%-33.755-24%-27.667-38%33.807-232%
Price To Total Gains Ratio-583.506+9%-644.271-242.323-62%-362.203-44%-187.939-71%-422.988-34%
Quick Ratio--1.3363.590-63%3.422-61%3.769-65%2.907-54%
Return On Assets---0.0140.000-100%-0.058+306%-0.046+223%-0.033+133%
Return On Equity---0.0150.005-397%-0.080+425%-0.086+460%-0.062+306%
Total Gains Per Share---12.01456.129-121%-52.224+335%16.302-174%45.592-126%
Usd Book Value--53820902.55249516024.576+9%44998899.430+20%51101345.920+5%46408976.623+16%
Usd Book Value Change Per Share---0.0100.045-121%-0.042+335%0.013-174%0.036-126%
Usd Book Value Per Share--0.8390.780+8%0.718+17%0.854-2%0.785+7%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.0130.003-533%-0.058+349%-0.049+283%-0.036+178%
Usd Free Cash Flow---2223449.872-692673.080-69%-10034375.522+351%-4296864.105+93%-3011899.973+35%
Usd Free Cash Flow Per Share---0.035-0.010-71%-0.160+362%-0.070+103%-0.049+42%
Usd Free Cash Flow To Equity Per Share---0.0350.039-190%0.015-336%0.057-161%0.046-175%
Usd Market Cap297652451.200-33%397261109.952621527076.848-36%819884824.400-52%651697779.400-39%661168027.290-40%
Usd Price Per Share5.608-10%6.1929.844-37%13.090-53%10.685-42%11.076-44%
Usd Profit---823432.464172729.652-577%-3606812.752+338%-2948107.178+258%-2140765.417+160%
Usd Revenue--3087306.0324246272.066-27%4408555.338-30%4160733.809-26%4363832.857-29%
Usd Total Gains Per Share---0.0100.045-121%-0.042+335%0.013-174%0.036-126%
 EOD+3 -5MRQTTM+10 -22YOY+23 -95Y+17 -1510Y+19 -13

3.2. Fundamental Score

Let's check the fundamental score of NatureCell Co.Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-109.236
Price to Book Ratio (EOD)Between0-16.685
Net Profit Margin (MRQ)Greater than0-0.267
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.336
Current Ratio (MRQ)Greater than115.501
Debt to Asset Ratio (MRQ)Less than10.074
Debt to Equity Ratio (MRQ)Less than10.080
Return on Equity (MRQ)Greater than0.15-0.015
Return on Assets (MRQ)Greater than0.05-0.014
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of NatureCell Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.502
Ma 20Greater thanMa 507,457.500
Ma 50Greater thanMa 1007,613.600
Ma 100Greater thanMa 2007,577.500
OpenGreater thanClose7,100.000
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets72,630,465
Total Liabilities5,354,337
Total Stockholder Equity67,276,128
 As reported
Total Liabilities 5,354,337
Total Stockholder Equity+ 67,276,128
Total Assets = 72,630,465

Assets

Total Assets72,630,465
Total Current Assets44,066,709
Long-term Assets28,563,756
Total Current Assets
Cash And Cash Equivalents 33,763,230
Net Receivables 3,799,360
Inventory 3,684,287
Other Current Assets 124,394
Total Current Assets  (as reported)44,066,709
Total Current Assets  (calculated)41,371,271
+/- 2,695,438
Long-term Assets
Property Plant Equipment 17,113,863
Goodwill 976,007
Intangible Assets 1,756,923
Long-term Assets Other 1,271,394
Long-term Assets  (as reported)28,563,756
Long-term Assets  (calculated)21,118,188
+/- 7,445,568

Liabilities & Shareholders' Equity

Total Current Liabilities2,842,814
Long-term Liabilities2,511,523
Total Stockholder Equity67,276,128
Total Current Liabilities
Accounts payable 437,155
Other Current Liabilities 0
Total Current Liabilities  (as reported)2,842,814
Total Current Liabilities  (calculated)437,155
+/- 2,405,659
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,759,778
Long-term Liabilities  (as reported)2,511,523
Long-term Liabilities  (calculated)2,759,778
+/- 248,256
Total Stockholder Equity
Total Stockholder Equity (as reported)67,276,128
Total Stockholder Equity (calculated)0
+/- 67,276,128
Other
Capital Stock32,078,578
Common Stock Shares Outstanding 64,157
Net Invested Capital 67,276,128
Net Working Capital 41,223,895
Property Plant and Equipment Gross 24,096,021



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
52,817,262
56,184,522
54,488,439
57,359,459
57,734,095
56,855,304
90,457,783
93,110,328
92,432,250
90,629,468
98,282,795
85,749,950
84,726,669
77,377,659
73,188,156
69,649,962
65,256,975
92,136,497
88,461,925
94,021,004
91,426,561
72,254,628
72,630,465
72,630,46572,254,62891,426,56194,021,00488,461,92592,136,49765,256,97569,649,96273,188,15677,377,65984,726,66985,749,95098,282,79590,629,46892,432,25093,110,32890,457,78356,855,30457,734,09557,359,45954,488,43956,184,52252,817,262
   > Total Current Assets 
16,102,271
19,073,599
20,458,294
21,359,447
21,008,972
23,540,781
56,710,445
55,894,260
54,893,217
53,710,699
60,905,528
56,333,935
55,365,253
48,138,766
44,539,427
42,901,357
40,011,020
69,194,001
64,949,652
67,162,791
58,966,613
38,893,647
44,066,709
44,066,70938,893,64758,966,61367,162,79164,949,65269,194,00140,011,02042,901,35744,539,42748,138,76655,365,25356,333,93560,905,52853,710,69954,893,21755,894,26056,710,44523,540,78121,008,97221,359,44720,458,29419,073,59916,102,271
       Cash And Cash Equivalents 
3,382,585
5,344,271
9,043,835
11,128,879
9,901,105
13,842,040
30,383,419
21,229,509
24,393,785
22,641,848
43,622,639
41,497,497
39,979,564
445
30
32,550,783
0
0
0
31,255,995
39,385,048
29,843,948
33,763,230
33,763,23029,843,94839,385,04831,255,99500032,550,7833044539,979,56441,497,49743,622,63922,641,84824,393,78521,229,50930,383,41913,842,0409,901,10511,128,8799,043,8355,344,2713,382,585
       Short-term Investments 
0
0
300,000
300,000
300,000
0
0
0
0
0
0
7,000,000
7,000,000
0
0
0
0
0
0
0
0
0
0
00000000007,000,0007,000,000000000300,000300,000300,00000
       Net Receivables 
5,892,230
7,284,643
4,007,649
3,918,858
4,508,900
3,978,365
4,417,887
3,131,720
3,806,170
4,149,890
3,956,892
2,905,941
3,035,445
2,966,788
2,362,033
5,346,436
5,885,455
6,060,079
7,349,213
9,178,568
4,931,252
3,332,656
3,799,360
3,799,3603,332,6564,931,2529,178,5687,349,2136,060,0795,885,4555,346,4362,362,0332,966,7883,035,4452,905,9413,956,8924,149,8903,806,1703,131,7204,417,8873,978,3654,508,9003,918,8584,007,6497,284,6435,892,230
       Inventory 
5,046,941
4,532,596
4,724,717
4,183,914
4,247,034
3,696,377
3,950,273
3,138,708
3,099,558
3,141,337
3,764,016
3,148,348
3,721,753
3,135,802
3,339,470
3,153,965
3,500,448
3,663,038
4,272,011
3,050,617
3,469,206
3,787,195
3,684,287
3,684,2873,787,1953,469,2063,050,6174,272,0113,663,0383,500,4483,153,9653,339,4703,135,8023,721,7533,148,3483,764,0163,141,3373,099,5583,138,7083,950,2733,696,3774,247,0344,183,9144,724,7174,532,5965,046,941
       Other Current Assets 
461,473
382,199
897,774
1,784,750
1,770,491
1,830,009
0
0
0
0
7,000,000
0
0
0
0
0
0
1,860,782
1,468,100
1,062,792
1,020,267
84,146
124,394
124,39484,1461,020,2671,062,7921,468,1001,860,7820000007,000,00000001,830,0091,770,4911,784,750897,774382,199461,473
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,858,213
32,459,948
33,360,981
28,563,756
28,563,75633,360,98132,459,94826,858,2130000000000000000000
       Property Plant Equipment 
11,188,231
11,203,570
11,105,300
11,016,763
10,962,871
10,904,065
10,460,611
12,098,104
12,558,295
11,568,618
12,154,236
9,334,316
9,625,004
9,741,448
9,336,932
8,530,864
7,617,240
7,366,688
7,415,055
9,605,642
15,719,713
15,448,624
17,113,863
17,113,86315,448,62415,719,7139,605,6427,415,0557,366,6887,617,2408,530,8649,336,9329,741,4489,625,0049,334,31612,154,23611,568,61812,558,29512,098,10410,460,61110,904,06510,962,87111,016,76311,105,30011,203,57011,188,231
       Goodwill 
0
0
0
0
0
0
976,007
976,007
976,007
976,007
976,007
976,007
976,007
1,031,536
1,031,536
1,031,536
1,031,536
976,007
976,007
976,007
976,007
976,007
976,007
976,007976,007976,007976,007976,007976,0071,031,5361,031,5361,031,5361,031,536976,007976,007976,007976,007976,007976,007976,007000000
       Long Term Investments 
16,744,343
16,917,320
14,569,275
16,247,508
16,659,960
12,760,748
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000012,760,74816,659,96016,247,50814,569,27516,917,32016,744,343
       Intangible Assets 
3,036,940
3,037,698
2,808,803
2,762,888
2,716,974
2,671,059
2,500,828
2,455,487
2,412,577
2,365,267
2,320,727
2,262,862
2,220,508
2,173,925
2,126,820
2,086,553
2,039,125
1,991,452
1,945,893
1,896,820
1,849,424
1,804,444
1,756,923
1,756,9231,804,4441,849,4241,896,8201,945,8931,991,4522,039,1252,086,5532,126,8202,173,9252,220,5082,262,8622,320,7272,365,2672,412,5772,455,4872,500,8282,671,0592,716,9742,762,8882,808,8033,037,6983,036,940
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,152,909
0
0
1,271,394
1,271,394001,152,9090000000000000000000
> Total Liabilities 
17,281,342
18,326,825
11,958,755
12,657,773
13,805,323
13,054,586
10,338,791
11,221,553
11,772,448
12,531,887
23,957,808
23,067,828
25,327,613
45,913,451
8,494,699
8,804,814
8,162,654
36,700,685
36,842,708
36,862,832
36,327,627
4,207,739
5,354,337
5,354,3374,207,73936,327,62736,862,83236,842,70836,700,6858,162,6548,804,8148,494,69945,913,45125,327,61323,067,82823,957,80812,531,88711,772,44811,221,55310,338,79113,054,58613,805,32312,657,77311,958,75518,326,82517,281,342
   > Total Current Liabilities 
9,931,857
11,001,997
9,656,416
10,515,476
13,066,327
12,557,881
9,802,362
8,839,920
9,350,778
10,195,811
21,428,488
20,517,508
22,822,107
43,174,886
5,841,346
6,578,475
6,075,406
34,812,433
35,298,870
35,752,449
35,123,639
3,120,896
2,842,814
2,842,8143,120,89635,123,63935,752,44935,298,87034,812,4336,075,4066,578,4755,841,34643,174,88622,822,10720,517,50821,428,48810,195,8119,350,7788,839,9209,802,36212,557,88113,066,32710,515,4769,656,41611,001,9979,931,857
       Short-term Debt 
8,671,734
46,000
46,000
46,000
1,802,000
1,802,000
2,240,000
2,240,000
2,240,000
4,190,000
4,190,000
4,190,000
4,190,000
0
0
0
0
0
0
0
0
0
0
00000000004,190,0004,190,0004,190,0004,190,0002,240,0002,240,0002,240,0001,802,0001,802,00046,00046,00046,0008,671,734
       Short Long Term Debt 
8,671,734
46,000
46,000
46,000
1,802,000
1,802,000
0
0
0
0
0
0
0
0
0
0
0
0
0
24,324,035
24,915,507
0
0
0024,915,50724,324,03500000000000001,802,0001,802,00046,00046,00046,0008,671,734
       Accounts payable 
1,507,279
1,730,022
1,059,072
1,276,321
1,219,438
1,149,667
0
0
0
0
0
0
0
0
0
0
0
0
0
1,069,726
1,039,167
657,418
437,155
437,155657,4181,039,1671,069,72600000000000001,149,6671,219,4381,276,3211,059,0721,730,0221,507,279
       Other Current Liabilities 
5,689,018
6,485,141
5,932,221
6,325,140
7,431,431
7,049,068
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000007,049,0687,431,4316,325,1405,932,2216,485,1415,689,018
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,110,383
1,203,989
1,086,842
2,511,523
2,511,5231,086,8421,203,9891,110,3830000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
34,500
1,874,092
1,831,112
1,686,827
1,860,967
1,868,982
1,938,261
1,820,469
1,540,170
1,361,784
948,360
949,185
829,778
679,809
744,416
615,500
0
0615,500744,416679,809829,778949,185948,3601,361,7841,540,1701,820,4691,938,2611,868,9821,860,9671,686,8271,831,1121,874,09234,500000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,207,217
1,455,706
1,244,775
2,759,778
2,759,7781,244,7751,455,7061,207,2170000000000000000000
       Other Liabilities 
963,751
856,668
431,339
282,797
646,996
416,205
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000416,205646,996282,797431,339856,668963,751
> Total Stockholder Equity
35,535,919
37,857,697
42,529,684
44,701,685
43,928,772
43,800,718
80,118,992
81,888,775
80,659,802
78,097,581
74,324,987
62,682,122
59,399,056
31,464,208
64,693,458
60,845,148
57,094,321
55,435,812
51,619,217
57,158,172
55,098,933
68,046,889
67,276,128
67,276,12868,046,88955,098,93357,158,17251,619,21755,435,81257,094,32160,845,14864,693,45831,464,20859,399,05662,682,12274,324,98778,097,58180,659,80281,888,77580,118,99243,800,71843,928,77244,701,68542,529,68437,857,69735,535,919
   Common Stock
25,539,676
25,875,426
26,416,200
26,468,200
26,528,200
26,528,200
30,595,200
30,595,200
30,595,200
30,595,200
30,595,200
30,595,200
30,653,228
30,678,228
31,313,578
31,313,578
31,318,578
31,318,578
31,318,578
31,318,578
31,328,578
32,078,578
0
032,078,57831,328,57831,318,57831,318,57831,318,57831,318,57831,313,57831,313,57830,678,22830,653,22830,595,20030,595,20030,595,20030,595,20030,595,20030,595,20026,528,20026,528,20026,468,20026,416,20025,875,42625,539,676
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
52,763,628
52,762,713
52,762,713
52,762,713
52,762,713
52,762,713
53,852,200
51,117,331
78,569,094
78,418,772
78,433,172
82,243,251
82,243,251
82,243,251
82,288,931
97,536,081
0
097,536,08182,288,93182,243,25182,243,25182,243,25178,433,17278,418,77278,569,09451,117,33153,852,20052,762,71352,762,71352,762,71352,762,71352,762,71352,763,628000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
3,637,207
3,430,195
3,811,295
4,413,322
4,650,178
3,586,877
0
0
0
0
0
0
0
0
0
0
0
0
0
-143,560
-36,955
-11,532
0
0-11,532-36,955-143,56000000000000003,586,8774,650,1784,413,3223,811,2953,430,1953,637,207



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue21,554,489
Cost of Revenue-12,208,984
Gross Profit9,345,5069,345,506
 
Operating Income (+$)
Gross Profit9,345,506
Operating Expense-28,839,685
Operating Income-7,909,474-19,494,179
 
Operating Expense (+$)
Research Development1,577,484
Selling General Administrative16,394,929
Selling And Marketing Expenses0
Operating Expense28,839,68517,972,413
 
Net Interest Income (+$)
Interest Income3,505,812
Interest Expense-1,723,710
Other Finance Cost-3,162,444
Net Interest Income-1,380,341
 
Pretax Income (+$)
Operating Income-7,909,474
Net Interest Income-1,380,341
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,904,828-7,909,474
EBIT - interestExpense = -1,723,710
-6,813,585
-5,089,876
Interest Expense1,723,710
Earnings Before Interest and Taxes (EBIT)0-7,181,118
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-8,904,828
Tax Provision-0
Net Income From Continuing Ops-8,904,828-8,904,828
Net Income-6,813,585
Net Income Applicable To Common Shares-6,813,585
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items2,091,243
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net01,380,341
 

Technical Analysis of Naturecell
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Naturecell. The general trend of Naturecell is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Naturecell's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of NatureCell Co.Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 7,150 < 7,220 < 8,260.

The bearish price targets are: 7,000 > 6,880.

Tweet this
NatureCell Co.Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of NatureCell Co.Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

NatureCell Co.Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of NatureCell Co.Ltd. The current macd is -156.66484771.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Naturecell price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Naturecell. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Naturecell price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
NatureCell Co.Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNatureCell Co.Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of NatureCell Co.Ltd. The current adx is 15.95.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Naturecell shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
NatureCell Co.Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of NatureCell Co.Ltd. The current sar is 7,730.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
NatureCell Co.Ltd Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of NatureCell Co.Ltd. The current rsi is 32.50. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
NatureCell Co.Ltd Daily Relative Strength Index (RSI) ChartNatureCell Co.Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of NatureCell Co.Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Naturecell price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
NatureCell Co.Ltd Daily Stochastic Oscillator ChartNatureCell Co.Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of NatureCell Co.Ltd. The current cci is -126.58462537.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
NatureCell Co.Ltd Daily Commodity Channel Index (CCI) ChartNatureCell Co.Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of NatureCell Co.Ltd. The current cmo is -51.45240418.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
NatureCell Co.Ltd Daily Chande Momentum Oscillator (CMO) ChartNatureCell Co.Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of NatureCell Co.Ltd. The current willr is -94.56521739.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
NatureCell Co.Ltd Daily Williams %R ChartNatureCell Co.Ltd Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of NatureCell Co.Ltd.

NatureCell Co.Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of NatureCell Co.Ltd. The current atr is 195.23.

NatureCell Co.Ltd Daily Average True Range (ATR) ChartNatureCell Co.Ltd Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of NatureCell Co.Ltd. The current obv is 8,160,885.

NatureCell Co.Ltd Daily On-Balance Volume (OBV) ChartNatureCell Co.Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of NatureCell Co.Ltd. The current mfi is 14.33.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
NatureCell Co.Ltd Daily Money Flow Index (MFI) ChartNatureCell Co.Ltd Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for NatureCell Co.Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-10-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-10-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-10-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-10-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

NatureCell Co.Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of NatureCell Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.502
Ma 20Greater thanMa 507,457.500
Ma 50Greater thanMa 1007,613.600
Ma 100Greater thanMa 2007,577.500
OpenGreater thanClose7,100.000
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Naturecell with someone you think should read this too:
  • Are you bullish or bearish on Naturecell? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Naturecell? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about NatureCell Co.Ltd

I send you an email if I find something interesting about NatureCell Co.Ltd.


Comments

How you think about this?

Leave a comment
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Stay informed about NatureCell Co.Ltd.

Receive notifications about NatureCell Co.Ltd in your mailbox!